Very early to tell and all breakouts at some point look at bit like a double bottom, but this looks a bit like a double bottom.
Been wanting to buy weed stocks since the high and all the way down. I think cannabinoids have many potential benefits and may be an important industry. Just didn't make sense while it was in a speculative bubble and didn't make sense when it was winding down that bubble in a protracted downtrend.
I think we've now reached a point where there's good RR on the long and we have a fairly reasonable way to define a stop betting on the double bottom formation.
Been wanting to buy weed stocks since the high and all the way down. I think cannabinoids have many potential benefits and may be an important industry. Just didn't make sense while it was in a speculative bubble and didn't make sense when it was winding down that bubble in a protracted downtrend.
I think we've now reached a point where there's good RR on the long and we have a fairly reasonable way to define a stop betting on the double bottom formation.
We may be inside of a crash event to 3000 in SPX.
Read the full case with backlog of historic analysis/forecasts here: holeyprofitnewsletter.substack.com/p/the-case-for-3000-in-spx
Read the full case with backlog of historic analysis/forecasts here: holeyprofitnewsletter.substack.com/p/the-case-for-3000-in-spx
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
We may be inside of a crash event to 3000 in SPX.
Read the full case with backlog of historic analysis/forecasts here: holeyprofitnewsletter.substack.com/p/the-case-for-3000-in-spx
Read the full case with backlog of historic analysis/forecasts here: holeyprofitnewsletter.substack.com/p/the-case-for-3000-in-spx
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.